13 unchanged sentences
In addition, from time to time, we have repurchased and may continue to repurchase common stock through private or other transactions outside of the Repurchase Program.
−Removed: From inception of the Repurchase Program through March 31, 2025, we have repurchased a total of $11,137 million of our securities under the Repurchase Program.
−Removed: During the three months ended March 31, 2025, we repurchased 2.3 million shares of our common stock for $425 million under the Repurchase Program.
−Removed: These amounts include 0.3 million of shares valued at $50 million, which were accrued for as of March 31, 2025 based on when the trade and settlement dates occurred.
+Added: From inception of the Repurchase Program through June 30, 2025, we have repurchased a total of $11,744 million of our securities under the Repurchase Program.
+Added: During the six months ended June 30, 2025, we repurchased 6.4 million shares of our common stock for $1,032 million under the Repurchase Program.
See Note 9 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional details regarding the Repurchase Program.
−Removed: As of March 31, 2025, inclusive of the accrued amounts, we had remaining authorization to repurchase up to $2,588 million of our common stock under the Repurchase Program.
−Removed: Since the merger between Quintiles and IMS Health, inclusive of accrued amounts, we have repurchased 86.9 million shares of our common stock at an average market price per share of $123.86 for an aggregate purchase price of $10,763 million both under and outside of the Repurchase Program.
+Added: As of June 30, 2025, we had remaining authorization to repurchase up to $1,981 million of our common stock under the Repurchase Program.
+Added: Since the merger between Quintiles and IMS Health, we have repurchased 91.0 million shares of our common stock at an average market price per share of $125.01 for an aggregate purchase price of $11,370 million both under and outside of the Repurchase Program.
This includes shares withheld from employees to satisfy certain tax obligations due in connection with grants of stock under the IQVIA Holdings Inc.
3 unchanged sentences
The shares of common stock withheld to satisfy tax withholding obligations may be deemed to be “issuer purchases” of shares that are required to be disclosed pursuant to this Item.
−Removed: The following table summarizes the monthly equity repurchase program activity for the three months ended March 31, 2025, and the approximate dollar value of shares that may yet be purchased pursuant to the Repurchase Program.
+Added: The following table summarizes the monthly equity repurchase program activity for the three months ended June 30, 2025, and the approximate dollar value of shares that may yet be purchased pursuant to the Repurchase Program.
(in millions, except per share data) Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
−Removed: January 1, 2025 — January 31, 2025 — $ — — $ 1,013
−Removed: February 1, 2025 — February 28, 2025 0.2 $ 187.21 0.2 $ 2,979
−Removed: March 1, 2025 — March 31, 2025 2.1 $ 182.54 2.1 $ 2,588
+Added: April 1, 2025 — April 30, 2025 1.0 $ 153.01 1.0 $ 2,435
+Added: May 1, 2025 — May 31, 2025 2.0 $ 146.79 2.0 $ 2,146
+Added: June 1, 2025 — June 30, 2025 1.1 $ 152.12 1.1 $ 1,981
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.